![Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-22446-z/MediaObjects/41467_2021_22446_Fig1_HTML.png)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications
![Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/10/6/e039978/F2.large.jpg?width=800&height=600&carousel=1)
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open
![Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013 | BMJ Open Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013 | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/5/9/e008932/F1.large.jpg?width=800&height=600&carousel=1)
Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013 | BMJ Open
![FACTORS RELATED TO THE COMPETITIVENESS OF THE COUNTRIES BRAZIL, ESTONIA AND MALAYSIA IN ATTRACTING GLOBAL CLINICAL TRIALS | Semantic Scholar FACTORS RELATED TO THE COMPETITIVENESS OF THE COUNTRIES BRAZIL, ESTONIA AND MALAYSIA IN ATTRACTING GLOBAL CLINICAL TRIALS | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/af17d19709502275f83bdb99486261c7bf45cd2d/6-Figure2-1.png)
FACTORS RELATED TO THE COMPETITIVENESS OF THE COUNTRIES BRAZIL, ESTONIA AND MALAYSIA IN ATTRACTING GLOBAL CLINICAL TRIALS | Semantic Scholar
![SciELO - Brasil - Avaliação de ensaios clínicos no Brasil: histórico e atualidades Avaliação de ensaios clínicos no Brasil: histórico e atualidades SciELO - Brasil - Avaliação de ensaios clínicos no Brasil: histórico e atualidades Avaliação de ensaios clínicos no Brasil: histórico e atualidades](https://minio.scielo.br/documentstore/1983-8034/Bhk4bDL8wYTZtPc6PrpWycQ/fc78ac4c306d8f51e9df061a49302e42e972285a.jpg)
SciELO - Brasil - Avaliação de ensaios clínicos no Brasil: histórico e atualidades Avaliação de ensaios clínicos no Brasil: histórico e atualidades
![Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19) - ScienceDirect Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S231941702030127X-gr1.jpg)
Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19) - ScienceDirect
![Vaccines | Free Full-Text | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | HTML Vaccines | Free Full-Text | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | HTML](https://www.mdpi.com/vaccines/vaccines-08-00474/article_deploy/html/images/vaccines-08-00474-g003.png)
Vaccines | Free Full-Text | Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2 | HTML
![Using the Cochrane Central Register of Controlled Trials to identify clinical trial registration is insufficient: a cross-sectional study | BMC Medical Research Methodology | Full Text Using the Cochrane Central Register of Controlled Trials to identify clinical trial registration is insufficient: a cross-sectional study | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01083-y/MediaObjects/12874_2020_1083_Fig2_HTML.png)
Using the Cochrane Central Register of Controlled Trials to identify clinical trial registration is insufficient: a cross-sectional study | BMC Medical Research Methodology | Full Text
GitHub - biomedical-translation-corpora/rebec: Clinical trials from the Brazilian Clinical Trials Registry - ReBEC
![SciELO - Brasil - Clinical trials sponsored by industry and other private organizations Clinical trials sponsored by industry and other private organizations SciELO - Brasil - Clinical trials sponsored by industry and other private organizations Clinical trials sponsored by industry and other private organizations](https://minio.scielo.br/documentstore/1807-3107/Z3GY38bxYzVPZ5SGFfp8VJv/74dc63ea053c885ed732148e3a972e5030525a1c.jpg)
SciELO - Brasil - Clinical trials sponsored by industry and other private organizations Clinical trials sponsored by industry and other private organizations
![The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine](https://blogs.biomedcentral.com/on-medicine/wp-content/uploads/sites/6/2020/05/who-map.jpg)
The WHO International Clinical Trials Registry Platform: Providing global clinical trial information to all - On Medicine
![Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries | BMJ Open Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/9/2/e025218/F4.large.jpg)
Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries | BMJ Open
![Reporting of methods was better in the Clinical Trials Registry-India than in Indian journal publications - Journal of Clinical Epidemiology Reporting of methods was better in the Clinical Trials Registry-India than in Indian journal publications - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5a9074b6-0813-42d4-a0cd-63441f75b5be/gr1_lrg.jpg)
Reporting of methods was better in the Clinical Trials Registry-India than in Indian journal publications - Journal of Clinical Epidemiology
![Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry - Journal of the Neurological Sciences Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry - Journal of the Neurological Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/29fb6ada-0cd6-4809-ac2f-545dc02c5bc7/gr1_lrg.jpg)
Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry - Journal of the Neurological Sciences
![Cumulative number of COVID-19 clinical trials in Brazil according to... | Download Scientific Diagram Cumulative number of COVID-19 clinical trials in Brazil according to... | Download Scientific Diagram](https://www.researchgate.net/profile/Fredi-Diaz-Quijano/publication/348309179/figure/fig1/AS:977388896796673@1610039080395/Cumulative-number-of-COVID-19-clinical-trials-in-Brazil-according-to-the-main-ongoing.png)
Cumulative number of COVID-19 clinical trials in Brazil according to... | Download Scientific Diagram
![REGISTRY SNAPSHOT: Brazilian Clinical Trials Registry / Registro Brasileiro de Ensaios Clínicos (ReBEC) - Trial Assure REGISTRY SNAPSHOT: Brazilian Clinical Trials Registry / Registro Brasileiro de Ensaios Clínicos (ReBEC) - Trial Assure](https://www.trialassure.com/wp-content/uploads/2019/01/2.-REGISTRY-SNAPSHOT-Brazilian-Clinical-Trials-Registry-%E2%80%A6-scaled-e1594010020817.jpg)
REGISTRY SNAPSHOT: Brazilian Clinical Trials Registry / Registro Brasileiro de Ensaios Clínicos (ReBEC) - Trial Assure
![SciELO - Saúde Pública - Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil SciELO - Saúde Pública - Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil](https://www.scielosp.org/media/assets/rbepid/v23/1980-5497-rbepid-23-e200104-gf1-en.jpg)
SciELO - Saúde Pública - Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil Avaliação da resposta inicial de desenvolvimento de ensaios clínicos para COVID-19 no Brasil
![Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America - Value in Health Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America - Value in Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c9e52ecc-b1ee-47a2-8683-2d6885ae00b2/gr1.jpg)